If you are new to TikTikTalk ? Your first verification mail might be in your spam folder.Check there and move it to your inbox to complete registration or account verification process..
Patrocinado
sociofans

Cell & Gene Therapy Manufacturing Services Market worth $11.5 Billion

0
2K

The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027. Growing prevalence of cancer and other other diseases, the surge in pharmaceutical R&D spending along with partnerships and agreements between pharmaceutical companies and CDMOs are some of the factors driving the market growth. On the contrary, the significant operational costs associated with cell and gene therapy manufacturing is expected to negatively impact the cell & gene therapy manufacturing market during the forecast period.

Request for Free Sample Report

Key Takeaways

  • The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027.
  • The cell therapy segment dominated the cell & gene therapy manufacturing services market in 2021.
  • North America was the largest regional market for cell & gene therapy manufacturing services market in 2021.
  • Lonza (Switzerland), Catalent (US), Thermo Fisher Scientific (US), Charles River Laboratories (US), WuXi AppTec (China), Merck KGaA (Germany), Takara Bio Inc. (Japan), Oxford Biomedica (UK), Cell and Gene Therapy Catapult (UK) are some of the key players in the cell & gene therapy manufacturing services market.

Market Drivers

  • Growing prevalence of cancer and other other diseases
  • Surge in pharmaceutical R&D spending
  • Partnerships and agreements between pharmaceutical companies and CDMOs
  • Expansion of cell and gene therapy manufacturing capacities by CDMOs

Market Restraints

  • Significant operational costs associated with cell and gene therapy manufacturing
  • Stringent regulatory requirements
  • Lack of skilled professionals

Market Opportunities

  • Increasing demand for cell and gene therapies
  • Growing number of clinical trials for cell and gene therapies
  • Development of new cell and gene therapy technologies

Market Trends

  • Increasing adoption of cell and gene therapy manufacturing services by pharmaceutical and biotechnology companies
  • Growing focus on partnerships and collaborations between pharmaceutical companies and CDMOs
  • Expansion of cell and gene therapy manufacturing capacities by CDMOs

Geographical Analysis

  • North America was the largest regional market for cell & gene therapy manufacturing services market in 2021.
  • Europe is expected to be the second-largest market for cell & gene therapy manufacturing services market during the forecast period.
  • Asia Pacific is expected to be the fastest-growing market for cell & gene therapy manufacturing services market during the forecast period.

Company Profiles

  • Lonza (Switzerland)
  • Catalent (US)
  • Thermo Fisher Scientific (US)
  • Charles River Laboratories (US)
  • WuXi AppTec (China)
  • Merck KGaA (Germany)
  • Takara Bio Inc. (Japan)
  • Oxford Biomedica (UK)
  • Cell and Gene Therapy Catapult (UK)
  • Genezen (US)
  • FUJIFILM Holdings Corporation (Japan)
  • Nikon Corporation (Japan)
  • The Discovery Labs LLC (US)
  • RoslinCT (Scotland)
  • JRS Pharma (Germany)
  • FinVector (Finland)
  • ABL, Inc. (US)
  • Resilience (US)
  • BioCentriq (US)
  • Porton Advanced Solutions (China)
  • Andelyn Biosciences (US)
  • Forge Biologics (US)
  • Vibalogics (US)
  • Anemocyte Srl (Italy)
  • ElevateBio (US)

Speak to Analyst

Recent Developments

  • In 2021, Charles River Laboratories acquired a cell & gene therapy CDMO—Cognate BioServices—to increase its cell and gene therapy manufacturing capabilities.
  • In 2021, Thermo Fisher Scientific acquired Henogen S.A., Novasep's viral vector manufacturing business in Belgium, for approximately USD 859.7 million. This acquisition will increase its presence in the cell & gene therapy manufacturing therapy market.
  • In 2019, Thermo Fisher Scientific acquired Brammer Bio, a company engaged in viral vector manufacturing for gene and cell therapies, for USD 1.7 billion.

Top 10 Companies in the Tissue Diagnostics Market
Top 10 Companies in Human Capital Management Market
Top 10 Companies Leading the Patient Engagement Solutions Market
Top 10 Companies in the Blood Collection Devices Market

Patrocinado
Patrocinado
Pesquisar
Patrocinado
Categorias
Leia Mais
Shopping
TUTX小煙機:時尚外觀、卓越性能與通用相容性的完美結合
在電子菸市場琳琅滿目的今天,選擇一款合適的電子菸杆變得尤為重要。TUTX電子煙主機以其時尚外觀、卓越性能和通用相容性,迅速成為消費者的理想選擇。本文將詳細介紹TUTX主機的特點和優勢,幫助您更好...
Por AnnaLise 2025-01-17 06:57:14 0 877
Fitness
Global Used Car Market To Rear Excessive Growth During 2024- 2032
The Winning Report [Growth Rate, Demands, Status, and Forecast 2032], published by Econ Market...
Por amelia78 2024-05-25 23:23:10 0 4K
Networking
Healthcare Staffing Market 2024-2032 Report | Industry Share, Size, Growth Drivers, Current Trends
    What is the Healthcare Staffing Market? The Healthcare Staffing market involves...
Por amelia78 2024-04-24 15:51:16 0 2K
Outro
Plumbing Fixtures Market to Hit USD 127.99 Billion by 2030 at a 6% CAGR
  The plumbing fixtures market is expected to grow at 6 % CAGR from 2024 to 2030. It is...
Por Monika312 2024-08-30 09:44:28 0 1K
Health
Infection Surveillance Solutions Market Share: Regional Growth and Forecast
The global infection surveillance solutions market share is expected to witness significant...
Por mattmile92 2023-11-14 13:41:54 0 3K
Patrocinado